You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 1, 2024

CLINICAL TRIALS PROFILE FOR MIZORIBINE

✉ Email this page to a colleague

« Back to Dashboard

Clinical Trials for Mizoribine

Subscribe to access the full database, or Try a Trial
Trial ID	Title	Status	Sponsor	Phase	Summary
NCT02005757 ↗	Efficacy and Safety Study of Mizoribine in Active Rheumatoid (AMOLED)	Unknown status	Chong Kun Dang Pharmaceutical	Phase 2	The purpose of this study is to access the efficacy and safety of Mizoribine 150mg qid and 50mg tid in active rheumatoid arthritis patients unsuccessfully treated with disease-modifying antirheumatic drug.
NCT02256150 ↗	A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis	Completed	Asahi Kasei Pharma Corporation	Phase 3	To demonstrate that the treatment effect in lupus nephritis of MZR is non-inferior to that of standard therapy CTX through analyzing overall remission rate after treatment.
NCT02257697 ↗	A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Refractory Nephrotic Syndrome	Completed	Asahi Kasei Pharma Corporation	Phase 3	To demonstrate that the treatment effect in refractory nephrotic syndrome of MZR is non-inferior to that of standard therapy CTX through analyzing overall remission rate after treatment.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Summary

Clinical Trial Conditions for Mizoribine

Condition Name

Chart
Table

Condition Name for
Intervention	Trials
Rheumatoid Arthritis	2
BK Virus	1
Kidney Transplant Recipients	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for
Intervention	Trials
Arthritis, Rheumatoid	2
Arthritis	2
Nephritis	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for Mizoribine

Trials by Country

Map
Table

Trials by Country for
Location	Trials
China	33
Korea, Republic of	1
Japan	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for Mizoribine

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for
Clinical Trial Phase	Trials
Phase 4	1
Phase 3	3
Phase 2	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for
Clinical Trial Phase	Trials
Completed	3
Not yet recruiting	1
Unknown status	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Mizoribine

Sponsor Name

Chart
Table

Sponsor Name for
Sponsor	Trials
Asahi Kasei Pharma Corporation	2
Chong Kun Dang Pharmaceutical	1
Regeneron Pharmaceuticals	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for
Sponsor	Trials
Industry	6
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.